NEW YORK STATE COMMON RETIREMENT FUND
PensionPosition in AKTS — Aktis Oncology, Inc.
CIK 810265
ALBANY, NY
Position in AKTS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$57,248
New position
Shares Held
3,200
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEW YORK STATE COMMON RETIREMENT FUND holds $807,320,680 across 235 Biotechnology names. AKTS ranks #190 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
292,414 | $130,574,547 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
117,369 | $90,683,984 | |
| 3 | INSM |
INSMED Inc
|
293,546 | $48,000,641 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
75,129 | $39,327,777 | |
| 5 | ASND |
Ascendis Pharma A/S
|
171,112 | $39,138,447 | |
| 6 | ARGX |
Argenx SE
|
39,437 | $28,798,869 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
350,414 | $26,312,587 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
119,839 | $23,925,856 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,248 | 3,200 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||